Ge Long Hui A P P

Search documents
真爱美家(003041.SZ):2025年半年度利润分配10派4元 股权登记日9月12日
Ge Long Hui A P P· 2025-09-05 09:19
格隆汇9月5日丨真爱美家(003041.SZ)公布,公司2025年半年度利润分配方案为:以公司现有总股本 144,000,000股为基数,向全体股东每10股派4元人民币现金(含税)。本次利润分配股权登记日2025年9月 12日。除权除息日2025年9月15日。 ...
灿瑞科技(688061.SH):董事长提议公司回购2000万元-4000万元股份
Ge Long Hui A P P· 2025-09-05 09:16
格隆汇9月5日丨灿瑞科技(688061.SH)公布,收到公司实际控制人、董事长罗立权先生《关于提议上海 灿瑞科技股份有限公司回购公司股份的函》。罗立权先生提议公司以自有资金和回购专项贷款通过上海 证券交易所交易系统以集中竞价交易方式回购公司股份,拟回购股份资金总额:不低于人民币2000万 元,不超过人民币4000万元。 ...
ST葫芦娃(605199.SH):获得头孢地尼胶囊药品注册证书
Ge Long Hui A P P· 2025-09-05 09:16
Core Viewpoint - ST HuLuWa (605199.SH) has received the drug registration certificate for Cefdinir capsules from the National Medical Products Administration, indicating a significant regulatory approval for the company’s product line [1] Group 1: Product Information - Cefdinir is a third-generation broad-spectrum cephalosporin antibiotic [1] - The drug is indicated for infections caused by various bacteria, including Staphylococcus, Streptococcus, and Escherichia coli, among others [1] - Specific infections treated by Cefdinir include pharyngitis, tonsillitis, acute bronchitis, pneumonia, otitis media, sinusitis, pyelonephritis, cystitis, and several skin and soft tissue infections [1]
步长制药(603858.SH)拟注销控股子公司步长医学诊断
Ge Long Hui A P P· 2025-09-05 09:14
格隆汇9月5日丨步长制药(603858.SH)公布,公司于2025年9月4日召开第五届董事会第三十一次会议, 审议通过了《关于拟注销步长(广州)医学诊断技术有限公司暨关联交易的议案》,为优化公司资源配 置,降低管理成本,公司拟注销步长(广州)医学诊断技术有限公司(称"步长医学诊断")。 ...
步长制药(603858.SH)拟放弃优先受让控股子公司步长鼎晟股权
Ge Long Hui A P P· 2025-09-05 09:14
格隆汇9月5日丨步长制药(603858.SH)公布,公司控股子公司步长鼎晟股东赵路拟将其持有的步长鼎晟 3.00%股权以4.2366万元转让给谢继辉,郭玉彪拟将其持有的步长鼎晟1.00%股权以1.4122万元转让给谢 继辉,蔡云飞拟将其持有的步长鼎晟1.00%股权以1.4122万元转让给何涛。公司同意放弃上述股权转让 的优先受让权。股权转让完成后,公司持有步长鼎晟94.00%股权比例。 ...
步长制药(603858.SH)拟受让步长药妆1.50%未实缴部分股权
Ge Long Hui A P P· 2025-09-05 09:14
格隆汇9月5日丨步长制药(603858.SH)公布,公司拟以0元人民币受让赵路持有的公司控股子公司步长药 妆1.50%未实缴部分股权。赵路拟将其未实缴的步长药妆1.00%股权转让给谢继辉、0.50%股权转让给王 奇,上述股权转让价格均为0元;公司同意放弃上述股权转让的优先受让权。股权转让完成后,公司持 有步长药妆94.50%股权比例。 ...
步长制药(603858.SH)拟将所持有的步长传方0.50%股权转让给何涛
Ge Long Hui A P P· 2025-09-05 09:14
Core Viewpoint - The company, Buchang Pharma (603858.SH), announced the transfer of equity stakes in Buchang Chuanfang, resulting in a reduction of its ownership to 92.5% after the transactions [1] Group 1: Equity Transfer Details - Buchang Pharma plans to transfer 0.50% of its stake in Buchang Chuanfang to He Tao for 0.6875 million RMB [1] - Zhao Lu intends to transfer a total of 3.00% of his stake in Buchang Chuanfang, with specific allocations: 1.00% to Xie Jihui for 1.375 million RMB, and 0.50% each to Xu Bao, Gao Ge Yan, Chen Mei Shou, and He Qian, each for 0.6875 million RMB [1] - The company has agreed to waive its preferential right to acquire the transferred equity [1]
步长制药(603858.SH):上海合璞拟对其全资子公司江苏合璞进行减资
Ge Long Hui A P P· 2025-09-05 09:14
格隆汇9月5日丨步长制药(603858.SH)公布,公司控股子公司上海合璞拟对其全资子公司江苏合璞进行 减资。本次减资完成后,江苏合璞的注册资本将由5,020万元减少至500万元,上海合璞仍持有江苏合璞 100%股权。 ...
龙虎榜丨三维通信跌7.92%,深股通净卖出1.74亿元
Ge Long Hui A P P· 2025-09-05 09:14
| 序号 | 交易营业部名称 | | 买入金额(万) | 占总成交比例 | | --- | --- | --- | --- | --- | | 1 深股通专用 | | 691次 46.89% 2 | 5433.62 | 1.58% | | 2 | 长江证券股份有限公司昆明白龙路证券营业部 | 15次 60.00% | 22.47 | 0.01% | | 3 | 中国银河证券股份有限公司绍兴证券营业部 | 41次 53.66% | 112.41 | 0.03% | | 4 | 中信证券股份有限公司浙江分公司 | 169次 35.50% | 2814.06 | 0.82% | | 5 | 平安证券股份有限公司深圳分公司 | 28次 32.14% | 129.26 | 0.04% | | | (买入前5名与卖出前5名)总合计: | | 23700.10 | 6.88% | 三维通信(002115.SZ)今日跌7.92%,换手率41.27%,成交额34.33亿元。龙虎榜数据显示,深股通买入5434万元,卖出2.28亿元,净卖出1.74亿元;游资"流沙 河"位列卖三席位,净卖出4359万元;"量化基金"位列卖五席位,净 ...
林洋能源(601222.SH):8月收到应收国家可再生能源补贴资金2.03亿元
Ge Long Hui A P P· 2025-09-05 09:11
Core Viewpoint - Lin Yang Energy (601222.SH) reported significant growth in renewable energy subsidy funds received in 2025, indicating strong performance in the renewable energy sector [1] Group 1: Financial Performance - The company received a total of 203 million yuan in renewable energy subsidy funds for its photovoltaic power generation projects by August 2025 [1] - From January 1 to August 31, 2025, the total renewable energy subsidy funds received amounted to 306 million yuan, representing a year-on-year increase of 210.10% [1] - The subsidy funds received in the first eight months of 2025 accounted for 177.09% of the total renewable energy subsidy funds received in the entire year of 2024 [1]